Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule interactions pharmacologically could compensate for Tau pathology
Prediction: Small molecules enhancing MAP6-microtubule binding will ameliorate cytoskeletal defects in tau knockout neurons and improve neuronal survival in amyloid toxicity models
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["MAPT/Tau Occupancy Dynamic Microtubule Binding"]
B["MAP6 Occupancy Cold-Stable Domain Support"]
C["Shared Microtubule Lattice Domain Allocation Competition"]
D["GSK3B/CRMP2 Cue Integration Plasticity Signaling"]
E["Axonal Remodeling Balance Stable vs Labile Segments"]
F["Transport and Branching Adaptive Circuit Plasticity"]
G["Tau-MAP6 Imbalance Rigid or Unstable Cytoskeleton"]
A --> C
B --> C
C --> D
D --> E
E --> F
G -.->|"disrupts"| C
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#1b5e20,stroke:#81c784,color:#81c784
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
1 citations0 with PMIDValidation: 0%1 supporting / 0 opposing
✓For(1)
No supporting evidence
No opposing evidence
(0)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
1
MECH 1CLIN 0GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
Aberrant MAP6 function may contribute to tau-indep…
Supporting
MECH
-
-
-
-
-
-
Legacy Card View — expandable citation cards
✓ Supporting Evidence
1
Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabil…▼
Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule interactions pharmacologically could compensate for Tau pathology
✗ Opposing Evidence
0
No evidence recorded
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Theoretical Evaluation: MAP6 and CRMPs in Neuronal Function and Neurodegeneration
1. Key Scientific Contributions
1.1 Unification of MAP6's Pleiotropic Functions Under a Single Conceptual Framework
This review synthesizes two decades of work demonstrating that MAP6 (STOP) is far more than a microtubule stabilizer. The authors establish MAP6 as a signaling scaffold that coordinates microtubule dynamics, actin cytoskeleton remodeling, and receptor trafficking. This reframing is significant because it positions MAP6 as a potential integrator of cytoskeletal responses to neuronal ac
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation: MAP6 and CRMPs Review Article
1. Key Methodological Weaknesses
1.1 Literature Synthesis Lacks Systematic Rigor
This is a narrative review, not a systematic review. The authors present their interpretation of "extensive data obtained over 20 years" without transparent inclusion/exclusion criteria for studies. This introduces selection bias—the review naturally emphasizes work from the authors' own laboratory (Grenoble Institut Neurosciences) while potentially underrepresenting conflicting findings. A cursory PubMed search reveals that several key authors appe
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Expert Assessment: MAP6 and CRMPs Review Article (PMID: 34025352)
1. Novelty Rating: 6/10
This review provides moderate conceptual novelty within the broader MAP/c cytoskeleton field.
Strengths:
First comprehensive synthesis linking MAP6 to such a diverse array of neuronal functions
The MAP6-CRMPS convergence framework is genuinely informative, as these protein families have been studied largely in parallel
The "beyond stabilization" framing articulates an important shift in thinking about MAPs generally
Limitations:
As a narrative review, novelty is constrained by
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
{"summary":"This 2021 review from the Grenoble research group synthesizes two decades of research on MAP6 (STOP), repositioning it from a simple microtubule stabilizer to a multifunctional signaling scaffold that coordinates cytoskeletal dynamics, actin remodeling, and receptor trafficking. The authors articulate a convergence framework linking MAP6 to the CRMP family (collapsin response mediator proteins), highlighting shared roles in semaphorin signaling, axon guidance, and GSK3β-mediated phosphorylation. The review extends MAP6 function beyond microtubule binding to encompass synaptic plast